These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3148149)

  • 1. Prolactin response to sodium valproate in schizophrenics with and without tardive dyskinesia.
    Monteleone P; Maj M; Ariano MG; Iovino M; Fiorenza L; Steardo L
    Psychopharmacology (Berl); 1988; 96(2):223-6. PubMed ID: 3148149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum neuroleptic activity, prolactin, and tardive dyskinesia in schizophrenic outpatients.
    Csernansky JG; Kaplan J; Holman CA; Hollister LE
    Psychopharmacology (Berl); 1983; 81(2):115-8. PubMed ID: 6138793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible associations among plasma prolactin levels, tardive dyskinesia, and paranoia in treated male schizophrenics.
    Csernansky JG; Prosser E; Kaplan J; Mahler E; Berger PA; Hollister LE
    Biol Psychiatry; 1986 Jun; 21(7):632-42. PubMed ID: 2871874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tardive dyskinesia predicts prolactin response to buspirone challenge in people with schizophrenia.
    Shim JC; Kim YH; Kelly DL; Lee JG; Conley RR
    J Neuropsychiatry Clin Neurosci; 2005; 17(2):221-6. PubMed ID: 15939977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral-type benzodiazepine-binding sites in platelets of schizophrenics with and without tardive dyskinesia.
    Weizman R; Tanne Z; Karp L; Tyano S; Gavish M
    Life Sci; 1986 Aug; 39(6):549-55. PubMed ID: 3016444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normal prolactin responses in tardive dyskinesia.
    Asnis GM; Sachar EJ; Langer G; Halpern FS; Fink M
    Psychopharmacology (Berl); 1979; 66(3):247-50. PubMed ID: 43550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased plasma brain-derived neurotrophic factor levels in schizophrenic patients with tardive dyskinesia: association with dyskinetic movements.
    Tan YL; Zhou DF; Zhang XY
    Schizophr Res; 2005 May; 74(2-3):263-70. PubMed ID: 15722005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative neurochemical investigation of tardive dyskinesia and neuroleptic-induced chronic parkinsonism.
    Arató M; Bagdy G; Perényi A; Béla A
    Psychiatry Res; 1984 Apr; 11(4):347-51. PubMed ID: 6146151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma prolactin and homovanillic acid as markers for psychopathology and abnormal movements after neuroleptic dose decrease.
    Newcomer JW; Riney SJ; Vinogradov S; Csernansky JG
    Psychopharmacol Bull; 1992; 28(1):101-7. PubMed ID: 1609034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased serum brain-derived neurotrophic factor levels in schizophrenic patients with tardive dyskinesia.
    Yang YQ; Sun S; Yu YQ; Li WJ; Zhang X; Xiu MH; Chen DC; De Yang F; Liu H; Li C; Kosten TR; Zhang XY
    Neurosci Lett; 2011 Sep; 502(1):37-40. PubMed ID: 21798311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum prolactin and tardive dyskinesia.
    Glazer WM; Moore DC; Bowers MD; Brown WA
    Am J Psychiatry; 1981 Nov; 138(11):1493-6. PubMed ID: 6117204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphocyte monoamine oxidase and plasma prolactin and growth hormone in tardive dyskinesia.
    Jeste DV; Neckers LM; Wagner RL; Wise CD; Staub RA; Rogol A; Potkin SG; Bridge TP; Wyatt RJ
    J Clin Psychiatry; 1981 Feb; 42(2):75-7. PubMed ID: 6109719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations among plasma prolactin levels, tardive dyskinesia, and paranoia in treated schizophrenics: relevance to supersensitivity psychosis.
    Csernansky JG; Vinogradov S; Prosser E; Kaplan J; Berger PA; Hollister LE
    Psychopharmacol Bull; 1986; 22(3):897-9. PubMed ID: 2879311
    [No Abstract]   [Full Text] [Related]  

  • 14. Sodium valproate and tardive dyskinesia.
    Gibson AC
    Br J Psychiatry; 1978 Jul; 133():82. PubMed ID: 352469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apomorphine and schizophrenia. Treatment, CSF, and neuroendocrine responses.
    Levy MI; Davis BM; Mohs RC; Kendler KS; Mathé AA; Trigos G; Horvath TB; Davis KL
    Arch Gen Psychiatry; 1984 May; 41(5):520-4. PubMed ID: 6372737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of sodium valproate and baclofen in tardive dyskinesia: clinical and neuroendocrine studies.
    Nair NP; Lal S; Schwartz G; Thavundayil JX
    Adv Biochem Psychopharmacol; 1980; 24():437-41. PubMed ID: 6773303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum vitamin B6 in schizophrenic and schizoaffective patients with and without tardive dyskinesia.
    Miodownik C; Lerner V; Cohen H; Kotler M
    Clin Neuropharmacol; 2000; 23(4):212-5. PubMed ID: 11020126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tardive dyskinesia in schizophrenia is associated with prolactin-related sexual disturbances.
    Tenback DE; van Harten PN; Slooff CJ; van Os J;
    Neuropsychopharmacology; 2006 Aug; 31(8):1832-7. PubMed ID: 16482082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of symptomatology of schizophrenia and tardive dyskinesia.
    Perenyi A; Norman T; Burrows GD
    Eur Neuropsychopharmacol; 1992 Mar; 2(1):51-5. PubMed ID: 1638174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma HVA, tardive dyskinesia and psychotic symptoms in long-term drug-free inpatients with schizophrenia.
    Muscettola G; Barbato G; de Bartolomeis A; Monteleone P; Pickar D
    Psychiatry Res; 1990 Sep; 33(3):259-67. PubMed ID: 2243901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.